PRDX2 and colorectal carcinoma: In contrast to the above findings, an earlier study by Ji et al. examined the mRNA and protein expression of Prx2 in CRC tissue of 137 patients and found lower Prx2 expression was associated with poor differentiation, advanced cancer stage and poorer survival.